These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 22842565

  • 1. Glucagon-like peptide-1 (GLP-1) induces M2 polarization of human macrophages via STAT3 activation.
    Shiraishi D, Fujiwara Y, Komohara Y, Mizuta H, Takeya M.
    Biochem Biophys Res Commun; 2012 Aug 24; 425(2):304-8. PubMed ID: 22842565
    [Abstract] [Full Text] [Related]

  • 2. The peptide-hormone glucagon-like peptide-1 activates cAMP and inhibits growth of breast cancer cells.
    Ligumsky H, Wolf I, Israeli S, Haimsohn M, Ferber S, Karasik A, Kaufman B, Rubinek T.
    Breast Cancer Res Treat; 2012 Apr 24; 132(2):449-61. PubMed ID: 21638053
    [Abstract] [Full Text] [Related]

  • 3. Oleanolic acid inhibits macrophage differentiation into the M2 phenotype and glioblastoma cell proliferation by suppressing the activation of STAT3.
    Fujiwara Y, Komohara Y, Kudo R, Tsurushima K, Ohnishi K, Ikeda T, Takeya M.
    Oncol Rep; 2011 Dec 24; 26(6):1533-7. PubMed ID: 21922144
    [Abstract] [Full Text] [Related]

  • 4. An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis.
    Baggio LL, Huang Q, Cao X, Drucker DJ.
    Gastroenterology; 2008 Apr 24; 134(4):1137-47. PubMed ID: 18313669
    [Abstract] [Full Text] [Related]

  • 5. Two small molecule agonists of glucagon-like peptide-1 receptor modulate the receptor activation response differently.
    Cheong YH, Kim MK, Son MH, Kaang BK.
    Biochem Biophys Res Commun; 2012 Jan 06; 417(1):558-63. PubMed ID: 22177947
    [Abstract] [Full Text] [Related]

  • 6. Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages.
    Soldano S, Pizzorni C, Paolino S, Trombetta AC, Montagna P, Brizzolara R, Ruaro B, Sulli A, Cutolo M.
    PLoS One; 2016 Jan 06; 11(11):e0166433. PubMed ID: 27846260
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
    Svegliati-Baroni G, Saccomanno S, Rychlicki C, Agostinelli L, De Minicis S, Candelaresi C, Faraci G, Pacetti D, Vivarelli M, Nicolini D, Garelli P, Casini A, Manco M, Mingrone G, Risaliti A, Frega GN, Benedetti A, Gastaldelli A.
    Liver Int; 2011 Oct 06; 31(9):1285-97. PubMed ID: 21745271
    [Abstract] [Full Text] [Related]

  • 9. Glucagon-like peptide 1 receptor expression in primary porcine proximal tubular cells.
    Schlatter P, Beglinger C, Drewe J, Gutmann H.
    Regul Pept; 2007 Jun 07; 141(1-3):120-8. PubMed ID: 17276524
    [Abstract] [Full Text] [Related]

  • 10. Glucagon-like peptide-1 suppresses advanced glycation end product-induced monocyte chemoattractant protein-1 expression in mesangial cells by reducing advanced glycation end product receptor level.
    Ishibashi Y, Nishino Y, Matsui T, Takeuchi M, Yamagishi S.
    Metabolism; 2011 Sep 07; 60(9):1271-7. PubMed ID: 21388644
    [Abstract] [Full Text] [Related]

  • 11. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
    Iwashita M, Sakoda H, Kushiyama A, Fujishiro M, Ohno H, Nakatsu Y, Fukushima T, Kumamoto S, Tsuchiya Y, Kikuchi T, Kurihara H, Akazawa H, Komuro I, Kamata H, Nishimura F, Asano T.
    Am J Physiol Endocrinol Metab; 2012 Feb 01; 302(3):E286-96. PubMed ID: 22045314
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Glucagon-like peptide-1 and its receptor agonist exendin-4 modulate cholangiocyte adaptive response to cholestasis.
    Marzioni M, Alpini G, Saccomanno S, Candelaresi C, Venter J, Rychlicki C, Fava G, Francis H, Trozzi L, Glaser S, Benedetti A.
    Gastroenterology; 2007 Jul 01; 133(1):244-55. PubMed ID: 17631146
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Does glucagon-like peptide-1 receptor agonist therapy add value in the treatment of type 2 diabetes? Focus on exenatide.
    van Genugten RE, van Raalte DH, Diamant M.
    Diabetes Res Clin Pract; 2009 Dec 01; 86 Suppl 1():S26-34. PubMed ID: 20115929
    [Abstract] [Full Text] [Related]

  • 16. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA.
    Oliver E, McGillicuddy FC, Harford KA, Reynolds CM, Phillips CM, Ferguson JF, Roche HM.
    J Nutr Biochem; 2012 Sep 01; 23(9):1192-200. PubMed ID: 22137266
    [Abstract] [Full Text] [Related]

  • 17. Glucagon-like peptide-1 upregulates visfatin expression in 3T3-L1 adipocytes.
    Liu R, Ding X, Wang Y, Wang M, Peng Y.
    Horm Metab Res; 2013 Sep 01; 45(9):646-51. PubMed ID: 23670349
    [Abstract] [Full Text] [Related]

  • 18. Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages.
    Guo C, Huang T, Chen A, Chen X, Wang L, Shen F, Gu X.
    Braz J Med Biol Res; 2016 Nov 21; 49(12):e5826. PubMed ID: 27878229
    [Abstract] [Full Text] [Related]

  • 19. The activation state of macrophages alters their ability to suppress preadipocyte apoptosis.
    Molgat AS, Gagnon A, Foster C, Sorisky A.
    J Endocrinol; 2012 Jul 21; 214(1):21-9. PubMed ID: 22556272
    [Abstract] [Full Text] [Related]

  • 20. The GLP-1 analogue lixisenatide decreases atherosclerosis in insulin-resistant mice by modulating macrophage phenotype.
    Vinué Á, Navarro J, Herrero-Cervera A, García-Cubas M, Andrés-Blasco I, Martínez-Hervás S, Real JT, Ascaso JF, González-Navarro H.
    Diabetologia; 2017 Sep 21; 60(9):1801-1812. PubMed ID: 28608285
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.